Hims & Hers Expands Care Scope as Digital Health Platforms Evolve

Core Insights - Hims & Hers Health, Inc. (HIMS) operates a digital health platform providing access to clinical care and wellness services, focusing on sexual health, dermatology, hair loss, mental health, and weight loss [2][3] - The company has expanded its clinical offerings, including low testosterone care and menopause treatments, and plans to introduce comprehensive lab-testing services and a longevity-focused specialty [3][7] - HIMS is also pursuing international growth through the acquisition of ZAVA in Europe and plans to enter the Canadian market in 2026 [3][7] Financial Performance - Hims & Hers shares have increased by 56.3% year to date, significantly outperforming the industry growth of 10.1% [6] - The forward 12-month price-to-sales (P/S) ratio for HIMS is 3.2X, lower than the industry average of 5X but higher than its three-year median of 2.6X [9] - The Zacks Consensus Estimate for HIMS' earnings per share (EPS) in 2025 indicates a 77.8% improvement from 2024 [9][10] Earnings Estimates - The current quarter EPS estimate is 0.04, with a next quarter estimate of 0.14, and a current year estimate of 0.48, projecting a year-over-year growth of 77.78% [10] - The next year EPS estimate is 0.60, reflecting a growth of 24.49% [10]